A new study carried out by the scientists of the Gladstone Institutes led by the senior researcher Katerina Akassoglou, Ph.D., shows that many of the new drugs currently being tested may not be sufficient to promote repair within the toxic environment of these cells and identifies a different treatment option that could improve myelin repair.
The study, conducted in collaboration with theUC San Diego and the University of Vienna, in Austria, was published in the magazine Brain.
New drugs for multiple sclerosis: here’s what the research says
In those affected by multiple sclerosis, the fatty substance that insulates the nerves of the central nervous system, called myelin, is damaged. This slows the transmission of signals from the brain to the rest of the body, causing movement difficulties, vision problems and cognitive changes.
Read Also
- Ivana Yturbe and Beto da Silva are expecting a girl: “Our hearts explode with happiness” Jul 8, 2021
- Car Maintenance – EP.4: Braking System | FormulaPassion.it Jul 18, 2021
- Cars | Incorrect guidance on car scrapping premiums has so far resulted in an additional bill of EUR 1.5 million for the state Jul 13, 2021
- GM aims for geothermal lithium for its Ultium batteries | FormulaPassion.it Jul 4, 2021
- DNI investigates cause of exit of electricity generating plants May 24, 2022
- Sergio George after acknowledging that Yahaira’s “Ulalá” was unsuccessful: “We can’t throw in the Jul 1, 2021
- The renewal of OPPO Watch would arrive at the end of the year and would boast autonomy | Technology May 28, 2021